Theorem Clinical Research

Archives

Choose a date range

From To

Choose one or more categories

Categories:



Show only original CenterWatch stories

 


Orgentec Diagnostika to acquire Corgenix

Friday, August 29, 2014 10:32 AM

Corgenix Medical, a Colorado-based, worldwide developer and marketer of diagnostic test kits, has agreed to be acquired by Orgentec Diagnostika, a specialty diagnostics company headquartered in Mainz, Germany. The strategic acquisition will extend both companies’ global distribution networks and broaden their portfoliod of specialty diagnostic assays.

More... »


Report: Total VC investment in second quarter highest since 2000

Friday, August 29, 2014 10:30 AM

Venture capitalists invested $13 billion in 1,114 deals in the second quarter of 2014, according to the MoneyTree Report from PricewaterhouseCoopers (PwC) and the National Venture Capital Association (NVCA), based on data provided by Thomson Reuters.

More... »


Ibraheem Mahmood named PharmaVOICE 100 most inspirational people

Thursday, August 28, 2014 03:09 PM

Ibraheem (Ibs) Mahmood, DrugDev president and CEO, has been named one of the PharmaVOICE 100 most inspiring people in the life sciences industry. DrugDev is a provider of technology-driven solutions that help investigators, sponsors and CROs do more trials together.

More... »

Scientists looking across human, fly and worm genomes find shared biology

Thursday, August 28, 2014 02:47 PM

Researchers analyzing human, fly, and worm genomes have found that these species have a number of key genomic processes in common, reflecting their shared ancestry.  The findings, appearing in the journal Nature, offer insights into embryonic development, gene regulation and other biological processes vital to understanding human biology and disease. 

More... »

Amgen submits BLA for evolocumab to the FDA

Thursday, August 28, 2014 02:14 PM

Amgen has submitted a Biologics License Application (BLA) to the FDA for evolocumab seeking approval for the treatment of high cholesterol. Evolocumab is an investigational, fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9), a protein that reduces the liver's ability to remove low-density lipoprotein cholesterol (LDL-C), or "bad" cholesterol, from the blood.

More... »

Mallinckrodt appoints new leaders following completion of Questcor acquisition

Thursday, August 28, 2014 02:07 PM

Mallinckrodt, an Ireland-based global specialty pharmaceutical company, has announced that Gary Phillips, M.D., current senior vice president and chief strategy officer, has been appointed senior vice president and president of the company’s autoimmune and rare disease business, which includes the commercial organization supporting H.P. Acthar Gel.

More... »

NIH releases new priority list of drugs it wants tested in children

Thursday, August 28, 2014 01:09 PM

The NIH has released a new "Priority List" of pediatric therapeutic areas and medical products it wants the medical community—including the pharmaceutical and biopharmaceutical industries—to focus on.

More... »

Survey: Pharma physicians support the principles of clinical trial transparency

Thursday, August 28, 2014 01:08 PM

The Faculty of Pharmaceutical Medicine (FPM), a professional membership organization of the Royal Colleges of Physicians of the U.K., has released results of its survey on the publication of clinical trial results and access to data.

More... »

NIH issues finalized policy on genomic data sharing

Thursday, August 28, 2014 01:05 PM

The NIH has issued a final NIH Genomic Data Sharing (GDS) policy to promote data sharing as a way to speed the translation of data into knowledge, products and procedures that improve health while protecting the privacy of research participants. The final policy was posted in the Federal Register Aug. 26 and published in the NIH Guide for Grants and Contracts Aug. 27.

More... »

Report: Cancer survival in England improving using cancer staging data

Wednesday, August 27, 2014 01:17 PM

Cancer survival in England for breast, lung, prostate, colorectal and ovarian cancer continues to improve, according to new data published in a report from Public Health England’s National Cancer Intelligence Network (NCIN).

More... »

CenterWatch Drugs in Clinical Trials
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 22

Roche/Genentech plans pilot trial to measure patientpreference for participating at home v. at study site

Bipartisan 21st Century Cures initiative prepares to draft legislation to accelerate biomedical R&D, lower cost

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

September

Today's fastest, most economical sponsors
Standout sponsors reveal how they shorten regulatory, clinical cycle times

From the trenches: Sites' eye view of state of the industry
CW’s first site focus groups uncover frustration with 'progress,' but a passion for their mission

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs